Results
еНаука >
Резултати >
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial
| Назив: | EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial | Аутори: | Rice, Andrew S C; Dworkin, Robert H; McCarthy, Tom D; Anand, Praveen; Bountra, Chas; McCloud, Philip I; Hill, Julie; Cutter, Gary; Kitson, Geoff; Desem, Nuket; | Година: | 2014 | Публикација: | The Lancet | ISSN: | 0140-6736 Lancet Претражи идентификатор |
Тип резултата: | Научни чланак | Колација: | vol. 383 br. 9929 str. 1637-1647 | DOI: | 10.1016/s0140-6736(13)62337-5 | WoS-ID: | 000335670800026 | Scopus-ID: | 2-s2.0-84900307488 | URI: | https://enauka.gov.rs/handle/123456789/307855 | Извор метаподатака: | Migrirano iz RIS podataka | М-категорија: | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.